DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 201 filers reported holding DIPLOMAT PHARMACY INC in Q4 2017. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,864,000 | -52.8% | 466,082 | -42.2% | 0.01% | -60.0% |
| Q3 2019 | $3,953,000 | -19.6% | 806,819 | -0.0% | 0.04% | -22.2% |
| Q2 2019 | $4,915,000 | +4.8% | 807,019 | -0.0% | 0.04% | 0.0% |
| Q1 2019 | $4,690,000 | -63.9% | 807,269 | -16.3% | 0.04% | -68.8% |
| Q4 2018 | $12,983,000 | -26.3% | 964,592 | +6.2% | 0.14% | -14.3% |
| Q3 2018 | $17,627,000 | -24.2% | 908,158 | -0.2% | 0.17% | -31.4% |
| Q2 2018 | $23,248,000 | +14.9% | 909,553 | -9.4% | 0.24% | +7.5% |
| Q1 2018 | $20,232,000 | -8.4% | 1,004,087 | -8.8% | 0.23% | -12.3% |
| Q4 2017 | $22,098,000 | -3.1% | 1,101,063 | -0.1% | 0.26% | -15.0% |
| Q3 2017 | $22,816,000 | +17.0% | 1,101,697 | -16.4% | 0.31% | +6.6% |
| Q2 2017 | $19,496,000 | -8.6% | 1,317,265 | -1.5% | 0.29% | -21.2% |
| Q1 2017 | $21,326,000 | +22.9% | 1,337,070 | -2.9% | 0.36% | +12.0% |
| Q4 2016 | $17,350,000 | -63.5% | 1,376,956 | -18.9% | 0.32% | -63.2% |
| Q3 2016 | $47,536,000 | -20.1% | 1,697,126 | -0.2% | 0.88% | -30.0% |
| Q2 2016 | $59,504,000 | +27.7% | 1,700,106 | -0.0% | 1.26% | +19.7% |
| Q1 2016 | $46,598,000 | +159.4% | 1,700,656 | +224.0% | 1.05% | +147.8% |
| Q4 2015 | $17,961,000 | +1178.4% | 524,872 | +973.1% | 0.42% | +962.5% |
| Q3 2015 | $1,405,000 | – | 48,911 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENMEDE TRUST CO NA | 420 | $1,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |